Adult Acute Lymphoblastic Leukemia
Overview Adult ALL is a malignant disease or cancer of the blood characterized by the rapid uncontrolled growth of abnormal, immature white blood cells known as lymphoblasts. There are approximately...
View ArticleAdult Acute Lymphoblastic Leukemia: Remission Induction
Overview Researchers have learned that the best way to cure patients with adult ALL is to administer large doses of several chemotherapeutic drugs over a short period of time. The concept is to kill...
View ArticleAdult Acute Lymphoblastic Leukemia: Post-Remission Treatment
Overview If a complete remission is achieved following remission induction therapy and no further treatment given, over 90% of patients will have a recurrence of leukemia in weeks to months. However,...
View ArticleRelapsed or Refractory Adult ALL
Overview Patients with progressive or relapsed adult ALL remain curable despite failing initial treatment. Patients failing treatment can be divided into two broad categories. Patients who fail to...
View ArticleSeptember Is National Leukemia and Lymphoma Awareness Month
As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention,...
View ArticleMany Patients with “Chemo Brain” Recover within Five Years
A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients....
View ArticleCaring for Yourself During Chemotherapy for Leukemia: How to Manage Hair...
Chemotherapy can be effective treatment for cancer but may also cause physical side effects that may be uncomfortable and affect your appearance. These side effects, however, are manageable. Hair Loss...
View ArticleDramatic Results Seen in Early Trials of Novel Lymphoma Treatment
A new treatment approach for B-Cell lymphoma patients developed at the National Cancer Institute (NCI) and licensed to Kite Pharmaceuticals is showing dramatic results in pilot clinical trials. The...
View ArticleClik here to view.
September Is National Blood Cancer Awareness Month
Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of blood cancer educational programs for national blood cancer awareness month. As the month of September brings blood...
View ArticleAmgen’s BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review...
THOUSAND OAKS, Calif., Oct. 9, 2014 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA)...
View ArticleClik here to view.
Ask the Expert: Blood Cancer Treatment Progress & What’s Next
CancerConnect Presents: Ask the Expert: Blood Cancer Treatment Progress & What’s Next In this informative web chat, Jacqueline Barrientos, MD discusses blood cancer prevalence, evolution of blood...
View ArticleAbout PCROWD, Dana-Farber’s tissue-banking study for patients with...
PCROWD (“Precursor CROWDsourcing”) – a tissue banking and clinical information study and repository – is an indispensable component of the blood cancer research pipeline. The main objective of PCROWD...
View ArticleFDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for...
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient...
View ArticlePass It On: July is National Leukemia and Lymphoma Awareness Month
Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society (ACS) estimates that there will be 60,140 new cases of leukemia...
View ArticleAdult Acute Lymphoblastic Leukemia
Overview Adult ALL is a malignant disease or cancer of the blood characterized by the rapid uncontrolled growth of abnormal, […] The post Adult Acute Lymphoblastic Leukemia appeared first on .
View ArticleAsk the Expert: Blood Cancer Treatment Progress & What’s Next
CancerConnect Presents: Ask the Expert: Blood Cancer Treatment Progress & What’s Next In this informative web chat, Jacqueline Barrientos, MD […] The post Ask the Expert: Blood Cancer Treatment...
View ArticleFDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for...
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the […] The post FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for...
View ArticlePass it On: It’s Leukemia and Lymphoma National Awareness Month
Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society […] The post Pass it On: It’s Leukemia and Lymphoma National...
View Article
